Good MorningThe equities market ended a strong week on an up note despite growing concerns about the COVID-19 pandemic. The number of new cases continues to set new records even as the broad market S&P 500 tries to set a new all-time closing high. The risk for markets is another shutdown. Although, President-Elect Joe Biden’s advisors backed off the suggestion to close the economy for 6 weeks the threat remains.
Next week could be challenging for the market. It is the mid-month data dump and includes eight major economic reports. Among them are Retail Sales, Business Inventories, The Index of Leading Indicators, and a host of housing data. Strong or stronger than expected figures could send the equity market to new all-time highs despite the threat of COVID and there is every reason to think they will be.
Featured: I interviewed 600 crypto millionaires – here's what's coming (Ad) 
|
Markets | | | Albert Marombe takes a grimy, tattered $1 note and delicately, expertly glues it back into one piece, holding it up for inspection.
“I don’t care how torn it is. All I want to see is the serial number being visible on both sides,” said Marombe. He'll sell that shabby $1 note for 80 ce... Read the Full Story |
|
|
Politics | | | WELLINGTON, New Zealand — New Zealand’s government could soon make wearing masks mandatory on public transit in Auckland and on planes nationwide as it continues to investigate a new community case of the coronavirus.
Virus Response Minister Chris Hipkins says there are no plans at t... Read the Full Story |
|
Politics | | | WELLINGTON, New Zealand — New Zealand’s government could soon make wearing masks mandatory on public transit in Auckland and on planes nationwide as it continues to investigate a new community case of the coronavirus.
Virus Response Minister Chris Hipkins says there are no plans at t... Read the Full Story |
|
|
Politics | | | SEOUL, South Korea -- South Korea has reported its biggest daily jump in COVID-19 cases in 70 days as the government began imposing fines for people who fail to wear masks in public.
The 191 cases added to the country’s caseload Friday represented the sixth consecutive day of over 100... Read the Full Story |
|
Markets | | |
When we consider which stocks have benefitted from market trends caused by the pandemic, usually the first ones that come to mind are cloud-based software companies, e-commerce companies, and any of the “stay-at-home” stocks. On the other hand, the brick-and-mortar retail industry has ... Read the Full Story |
|
From Our PartnersWith the next presidential cycle heating up and Trump leading the charge, major market shifts are already taking shape.
For investors who position early, the opportunities could be significant.
That’s why we’ve just released a brand-new report:
📈 “5 Best Stocks to Buy Under Trump’s Presidency.” | | | Get the full report here—and stay ahead of the curve. |
|
Markets | | | Farfetch (NYSE:FTCH) is a company that provides a technology platform for the global fashion industry. The stock is trading near its all-time highs thanks to a recent announcement that Alibaba (NYSE:BABA) will invest millions Read the Full Story |
|
Markets | | | A civil court trial began Friday in Japan over Nissan’s demand for 10 billion yen, or $95 million, in damages from its former chairman, Carlos Ghosn.
The automaker has sued Ghosn over what it says is harm suffered from various types of alleged financial misconduct. Ghosn jumped bail ... Read the Full Story |
|
Stocks | | |
It's been a tough year for the restaurant industry. Most companies have struggled to put food on the table amid pandemic-led shutdowns and restrictions. There have however been a handful of standout performers that have managed to not just survive but produce some impressive performances despite t... Read the Full Story |
|
Markets | | | It’s been a full quarter since I last reviewed Advanced Auto Parts (NYSE:AAP) and the situation is only more attractive. At the time, I saw the stock on the verge of a breakout and urged investors to wait for a pullback before buying. Read the Full Story |
|
Markets | | |
There's a school of thought that says job cuts are good for a company's share price because it demonstrates that the company is willing to make the “tough calls” to improve the bottom line. If that's the case, then AT&T (NYSE:T) should be in line for some big gains of its own as th... Read the Full Story |
|
The Early Bird Stock Of The Day Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for eye care in the United States. The company's lead product candidate is XDEMVY, a novel therapeutic for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. It is developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. In addition, the company develops lotilaner to address diseases across therapeutic categories in human medicine, including eye care, dermatology, and other infectious disease prevention. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California. | | View Today's Stock Pick |
|
